BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 11345011)

  • 1. Motor neuron disease.
    Jackson CE; Rosenfeld J
    Phys Med Rehabil Clin N Am; 2001 May; 12(2):335-52, ix-x. PubMed ID: 11345011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyotrophic lateral sclerosis.
    Jackson CE; Bryan WW
    Semin Neurol; 1998; 18(1):27-39. PubMed ID: 9562665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cotreatment of amyotrophic lateral sclerosis patients].
    Iwasaki Y; Ikeda K
    Rinsho Shinkeigaku; 1999 Dec; 39(12):1253-5. PubMed ID: 10791091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Riluzole slows the progression of neuromuscular dysfunction in the wobbler mouse motor neuron disease.
    Ishiyama T; Okada R; Nishibe H; Mitsumoto H; Nakayama C
    Brain Res; 2004 Sep; 1019(1-2):226-36. PubMed ID: 15306257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000.
    Traynor BJ; Alexander M; Corr B; Frost E; Hardiman O
    J Neurol; 2003 Apr; 250(4):473-9. PubMed ID: 12700914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor neuron disease associated with copper deficiency.
    Weihl CC; Lopate G
    Muscle Nerve; 2006 Dec; 34(6):789-93. PubMed ID: 16929546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene-based treatment of motor neuron diseases.
    Federici T; Boulis NM
    Muscle Nerve; 2006 Mar; 33(3):302-23. PubMed ID: 16228969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Amyotrophic lateral sclerosis].
    Moriwaka F
    Hokkaido Igaku Zasshi; 1997 Jan; 72(1):21-5. PubMed ID: 9086359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroprotective therapy for amyotrophic lateral sclerosis (ALS)].
    Yanagisawa N; Shindo M
    Rinsho Shinkeigaku; 1996 Dec; 36(12):1329-30. PubMed ID: 9128396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preface: the state of the science of all motor neuron diseases.
    Weiss MD; Carter GT
    Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):xix-xx. PubMed ID: 18625405
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical differentiation between primary lateral sclerosis and upper motor neuron predominant amyotrophic lateral sclerosis.
    Gotkine M; Argov Z
    Arch Neurol; 2007 Oct; 64(10):1545; author reply 1545. PubMed ID: 17923644
    [No Abstract]   [Full Text] [Related]  

  • 13. Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis.
    Sach M; Winkler G; Glauche V; Liepert J; Heimbach B; Koch MA; Büchel C; Weiller C
    Brain; 2004 Feb; 127(Pt 2):340-50. PubMed ID: 14607785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do the benefits of currently available treatments justify early diagnosis and announcement? Arguments for.
    Cashman NR
    Neurology; 1999; 53(8 Suppl 5):S50-2; discussion S55-7. PubMed ID: 10560639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary lateral sclerosis: a rare upper-motor-predominant form of amyotrophic lateral sclerosis often accompanied by frontotemporal lobar degeneration with ubiquitinated neuronal inclusions? Report of an autopsy case and a review of the literature.
    Tan CF; Kakita A; Piao YS; Kikugawa K; Endo K; Tanaka M; Okamoto K; Takahashi H
    Acta Neuropathol; 2003 Jun; 105(6):615-20. PubMed ID: 12734667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Objective markers for upper motor neuron involvement in amyotrophic lateral sclerosis].
    Iwata NK
    Brain Nerve; 2007 Oct; 59(10):1053-64. PubMed ID: 17969345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyotrophic lateral sclerosis and primary lateral sclerosis: The role of diffusion tensor imaging and other advanced MR-based techniques as objective upper motor neuron markers.
    Wang S; Melhem ER
    Ann N Y Acad Sci; 2005 Dec; 1064():61-77. PubMed ID: 16394148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary lateral sclerosis, hereditary spastic paraplegia and amyotrophic lateral sclerosis: discrete entities or spectrum?
    Strong MJ; Gordon PH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Mar; 6(1):8-16. PubMed ID: 16036421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do the benefits of currently available treatments justify early diagnosis and treatment of amyotrophic lateral sclerosis? Arguments against.
    Ludolph AC; Riepe MW
    Neurology; 1999; 53(8 Suppl 5):S46-9; discussion S55-7. PubMed ID: 10560638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
    Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
    Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.